Walgreen Blasts 'Chutzpah' Of Attys' Fee Bid In Pfizer MDL
By Aaron Vehling · September 15, 2014, 4:02 PM EDT
Walgreen Co. urged a New Jersey federal court Friday to deny class counsel a cut of the fees from Walgreen's antitrust settlement with Pfizer Inc. over its epilepsy treatment Neurontin, saying...
To view the full article, register now.